391 related articles for article (PubMed ID: 27346606)
1. A pilot study for triple combination therapy with a low-fluence 1064 nm Q-switched Nd:YAG laser, hydroquinone cream and oral tranexamic acid for recalcitrant Riehl's Melanosis.
Kwon HH; Ohn J; Suh DH; Park HY; Choi SC; Jung JY; Kwon IH; Park GH
J Dermatolog Treat; 2017 Mar; 28(2):155-159. PubMed ID: 27346606
[TBL] [Abstract][Full Text] [Related]
2. Non-Ablative 1927 nm Fractional Thulium Fiber Laser: New, Promising Treatment Modality for Riehl's Melanosis.
Kim SM; Hwang S; Almurayshid A; Park MY; Oh SH
Lasers Surg Med; 2021 Jul; 53(5):640-646. PubMed ID: 33259661
[TBL] [Abstract][Full Text] [Related]
3. Low-pulse energy Q-switched Nd:YAG laser treatment for hair-dye-induced Riehl's melanosis.
On HR; Hong WJ; Roh MR
J Cosmet Laser Ther; 2015 Jun; 17(3):135-8. PubMed ID: 25602355
[TBL] [Abstract][Full Text] [Related]
4. A pilot study of a novel dual--pulsed 1064 nm Q-switched Nd: YAG laser to treat Riehl's melanosis.
Chung BY; Kim JE; Ko JY; Chang SE
J Cosmet Laser Ther; 2014 Dec; 16(6):290-2. PubMed ID: 25046351
[TBL] [Abstract][Full Text] [Related]
5. Successful Treatment of Riehl's Melanosis With Mid-Fluence Q-Switched Nd:YAG 1064-nm Laser.
Cho MY; Roh MR
Lasers Surg Med; 2020 Oct; 52(8):753-760. PubMed ID: 31951050
[TBL] [Abstract][Full Text] [Related]
6. A pilot study of oral tranexamic acid and Glycyrrhizin compound in the treatment of recalcitrant Riehl's melanosis.
Xu Z; Xing X; Zhang C; Chen L; Flora Xiang L
J Cosmet Dermatol; 2019 Feb; 18(1):286-292. PubMed ID: 30341831
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and safety of the combination of oral tranexamic acid and intense pulsed light versus oral tranexamic acid alone in the treatment of refractory Riehl's melanosis: A prospective, comparative study.
Xu Z; Wang C; Xing X; Zhang C; Xiang LF
J Cosmet Dermatol; 2024 Jun; 23(6):2049-2057. PubMed ID: 38456556
[TBL] [Abstract][Full Text] [Related]
8. A novel treatment for Riehl's melanosis targeting both dermal melanin and vessels.
Kim YH; Park YJ; Baek DJ; Kwon JE; Kang HY
Photodermatol Photoimmunol Photomed; 2023 Nov; 39(6):613-619. PubMed ID: 37612856
[TBL] [Abstract][Full Text] [Related]
9. Analysis of Clinical Features and Treatment Outcomes Using 1,064-nm Nd-YAG Laser with Topical Hydroquinone in Patients with Riehl's Melanosis: A Retrospective Study in 10 Patients.
Choi CW; Jo G; Lee DH; Jo SJ; Lee C; Mun JH
Ann Dermatol; 2019 Apr; 31(2):127-132. PubMed ID: 33911560
[TBL] [Abstract][Full Text] [Related]
10. A split-face, investigator-blinded comparative study on the efficacy and safety of Q-switched Nd:YAG laser plus microneedling with vitamin C versus Q-switched Nd:YAG laser for the treatment of recalcitrant melasma.
Ustuner P; Balevi A; Ozdemir M
J Cosmet Laser Ther; 2017 Nov; 19(7):383-390. PubMed ID: 28657378
[TBL] [Abstract][Full Text] [Related]
11. Combination therapy with salicylic acid chemical peels, glycyrrhizin compound, and vitamin C for Riehl's melanosis.
Wang L; Wen X; Hao D; Li Y; Du D; Jiang X
J Cosmet Dermatol; 2020 Jun; 19(6):1377-1380. PubMed ID: 31524950
[TBL] [Abstract][Full Text] [Related]
12. Unveiling the mystery of Riehl's melanosis: An update from pathogenesis, diagnosis to treatment.
Ding Y; Xu Z; Xiang LF; Zhang C
Pigment Cell Melanoma Res; 2023 Nov; 36(6):455-467. PubMed ID: 37401632
[TBL] [Abstract][Full Text] [Related]
13. Topical 3% tranexamic acid enhances the efficacy of 1064-nm Q-switched neodymium-doped yttrium aluminum garnet laser in the treatment of melasma.
Laothaworn V; Juntongjin P
J Cosmet Laser Ther; 2018 Oct; 20(6):320-325. PubMed ID: 29461121
[No Abstract] [Full Text] [Related]
14. A randomized, split-face clinical trial of low-fluence Q-switched neodymium-doped yttrium aluminum garnet (1,064 nm) laser versus low-fluence Q-switched alexandrite laser (755 nm) for the treatment of facial melasma.
Fabi SG; Friedmann DP; Niwa Massaki AB; Goldman MP
Lasers Surg Med; 2014 Sep; 46(7):531-7. PubMed ID: 24895301
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and safety of a novel picosecond laser using combination of 1 064 and 595 nm on patients with melasma: A prospective, randomized, multicenter, split-face, 2% hydroquinone cream-controlled clinical trial.
Choi YJ; Nam JH; Kim JY; Min JH; Park KY; Ko EJ; Kim BJ; Kim WS
Lasers Surg Med; 2017 Dec; 49(10):899-907. PubMed ID: 28906574
[TBL] [Abstract][Full Text] [Related]
16. Q-switched Nd: YAG laser alone or with modified Jessner chemical peeling for treatment of mixed melasma in dark skin types: A comparative clinical, histopathological, and immunohistochemical study.
Saleh F; Moftah NH; Abdel-Azim E; Gharieb MG
J Cosmet Dermatol; 2018 Jun; 17(3):319-327. PubMed ID: 29057567
[TBL] [Abstract][Full Text] [Related]
17. Oral tranexamic acid, hydroquinone 4% and low-fluence 1064 nm Q-switched Nd:YAG laser for mixed melasma: Clinical and dermoscopic evaluation.
Elkamshoushi AM; Romisy D; Omar SS
J Cosmet Dermatol; 2022 Feb; 21(2):657-668. PubMed ID: 33826785
[TBL] [Abstract][Full Text] [Related]
18. Effects of a fractional picosecond 1,064 nm laser for the treatment of dermal and mixed type melasma.
Chalermchai T; Rummaneethorn P
J Cosmet Laser Ther; 2018 Jun; 20(3):134-139. PubMed ID: 29020467
[TBL] [Abstract][Full Text] [Related]
19. Retrospective analysis of melasma treatment using a dual mode of low-fluence Q-switched and long-pulse Nd:YAG laser vs. low-fluence Q-switched Nd:YAG laser monotherapy.
Choi CP; Yim SM; Seo SH; Ahn HH; Kye YC; Choi JE
J Cosmet Laser Ther; 2015 Feb; 17(1):2-8. PubMed ID: 25151913
[TBL] [Abstract][Full Text] [Related]
20. A split face study to document the safety and efficacy of clearance of melasma with a 5 ns q switched Nd YAG laser versus a 50 ns q switched Nd YAG laser.
Alsaad SM; Ross EV; Mishra V; Miller L
Lasers Surg Med; 2014 Dec; 46(10):736-40. PubMed ID: 25411141
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
